SCHEMBL29312135

SCHEMBL29312135

c1ccc(-c2ccc(-c3ccc(N(c4ccc(-c5ccccc5)cc4)c4cc(-c5ccc(-c6ccccc6)cc5)c5sc6ccccc6c5c4)cc3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNKS O95271 1/20 0.43
▸ TNKS2 Q9H2K2 1/20 0.43
▸ ALOX5 P09917 1/20 0.43
▸ MAPT P10636 3/20 0.36
▸ GPR3 P46089 1/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ ATM Q13315 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ LIMK1 P53667 2/20 0.35
▸ PIM3 Q86V86 2/20 0.34
▸ F9 P00740 1/20 0.34
▸ PARP14 Q460N5 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ PTPN1 P18031 2/20 0.32
▸ APP P05067 1/20 0.31
▸ PIM1 P11309 1/20 0.31
▸ PIM2 Q9P1W9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19606993 1.00 TNKS (0.43) TNKSTNKS2ALOX5MAPTGPR3
SCHEMBL29312109 1.00 TNKS (0.43) TNKSTNKS2ALOX5MAPTGPR3
SCHEMBL29312110 0.99 TNKS (0.42) TNKSTNKS2ALOX5MAPTGPR3
SCHEMBL29312096 0.99 TNKS (0.42) TNKSTNKS2ALOX5MAPTGPR3
SCHEMBL29312136 0.99 TNKS (0.42) TNKSTNKS2ALOX5MAPTGPR3
SCHEMBL29312125 0.99 TNKS (0.42) TNKSTNKS2ALOX5MAPTGPR3
SCHEMBL29312100 0.99 TNKS (0.42) TNKSTNKS2ALOX5MAPTGPR3
SCHEMBL22045388 0.96 ALOX5 (0.43) TNKSTNKS2ALOX5MAPTGPR3
SCHEMBL22045655 0.94 ALOX5 (0.44) TNKSTNKS2ALOX5MAPTGPR3
SCHEMBL29312098 0.94 ALOX5 (0.41) TNKSTNKS2ALOX5MAPTGPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12041848-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2024-07-16 — — US disclosed
US-12041848-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2024-07-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12041848-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, NR2E3 TNKS 3740/4885TNKS2 3550/4885ALOX5 1089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback